Interne link ProQR Therapeutics Announces Transaction Completed for Théa to Acquire Sepofarsen and Ultevursen Ophthalmic Assets december 08, 2023 om 12:30 PM UTC
Interne link ProQR Announces Third Quarter 2023 Operating and Financial Results november 07, 2023 om 12:00 PM UTC
Interne link ProQR Strengthens Leading Intellectual Property Estate for ADAR-mediated RNA Editing november 06, 2023 om 12:00 PM UTC
Interne link ProQR Announces Participation in the Chardan 7th Annual Genetic Medicines Conference september 28, 2023 om 12:00 PM UTC
Interne link ProQR Therapeutics Provides Update on Ophthalmic Assets september 27, 2023 om 11:00 AM UTC
Interne link ProQR Announces Webcast of Presentation at the Upcoming HC Wainwright 25th Annual Global Investment Conference september 07, 2023 om 12:00 PM UTC
Interne link ProQR Announces Second Quarter 2023 Operating and Financial Results augustus 03, 2023 om 11:00 AM UTC
Interne link ProQR Therapeutics and Laboratoires Théa Announce Agreement for Théa to Acquire ProQR’s Sepofarsen and Ultevursen Ophthalmic Assets augustus 01, 2023 om 11:00 AM UTC
Interne link ProQR to Present Data on its Axiomer® RNA Editing Technology at RNA Editing Summit juli 06, 2023 om 11:00 AM UTC
Interne link ProQR Announces First Quarter 2023 Operating and Financial Results mei 16, 2023 om 11:00 AM UTC
Interne link ProQR to Present its Axiomer® RNA Editing Technology at TIDES USA 2023 mei 09, 2023 om 12:00 PM UTC
Interne link ProQR Announces Upcoming Investor Conferences in April and May april 20, 2023 om 12:00 PM UTC
Interne link ProQR Announces Annual Meeting of Shareholders to be Held May 17, 2023 april 18, 2023 om 12:00 PM UTC
Interne link ProQR Announces Initial Pipeline Targets and Highlights Axiomer® RNA Editing Platform Technology at R&D Event maart 29, 2023 om 12:00 PM UTC
Interne link ProQR Announces Successful Defense of a Key Axiomer® Patent Protecting ADAR-mediated RNA Editing maart 14, 2023 om 12:00 PM UTC
Interne link ProQR to Present at Upcoming Scientific and Industry Conferences maart 07, 2023 om 01:00 PM UTC
Interne link ProQR Therapeutics to Host Virtual R&D Event on March 29, 2023 februari 28, 2023 om 01:00 PM UTC
Interne link ProQR Announces Amendment to Convertible Debt Financing Agreement with Pontifax Ventures and Kreos Capital december 30, 2021 om 12:00 PM UTC
Interne link ProQR Announces First Patients Dosed in Phase 2/3 Pivotal Trials of QR-421a for USH2A Mediated Retinitis Pigmentosa december 16, 2021 om 12:00 PM UTC
Interne link ProQR Announces Upcoming Investor Conferences in November and December november 08, 2021 om 09:30 PM UTC
Interne link ProQR Announces Third Quarter 2021 Operating and Financial Results november 04, 2021 om 11:00 AM UTC
Interne link ProQR Appoints Theresa Heggie as Chief Commercial Officer oktober 04, 2021 om 12:00 PM UTC
Interne link ProQR Announces Conference Call to Discuss the Axiomer® RNA Editing Platform september 08, 2021 om 08:15 PM UTC